The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotype
- 18 August 1995
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 196 (1) , 105-108
- https://doi.org/10.1016/0304-3940(95)11860-y
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The influence of apolipoprotein E isotypes on alzheimer's disease pathology in 40 cases of down's syndromeAnnals of Neurology, 1995
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- Frequency of the apolipoprotein E ε2 allele is diminished in sporadic Alzheimer diseaseNeuroscience Letters, 1994
- Apolipoprotein E genes in Lewy body and Parkinson's diseaseThe Lancet, 1994
- Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other β-amyloid-forming diseasesThe Lancet, 1994
- β/A4 deposition, neural degeneration and synapse pathology in Alzheimer patients of different apolipoprotein E genotypesNeurobiology of Aging, 1994
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactionsNeuron, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Soluble β-amyloid precursor protein and pyramidal neuron lossThe Lancet, 1993